NASDAQ: CRME TSX: COM
VANCOUVER, Nov. 1 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Doug Janzen, President and CEO, is scheduled to present an overview of Cardiome at the 21st Annual Oppenheimer Healthcare Conference in New York on Tuesday, November 2, 2010 at 3:20pm Eastern (12:20pm Pacific).
A live webcast of Mr. Janzen's presentation can be accessed on Cardiome's website at www.cardiome.com. A replay of the webcast will be posted after the presentation and will be available until December 2, 2010.
About Cardiome Pharma Corp.
Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on the NASDAQ Global Market (CRME) and the Toronto Stock Exchange (COM). For more information, please visit our web site at www.cardiome.com.
SOURCE Cardiome Pharma Corp.